Redcare Phamacy Unsp/Adr (SAEYY) Q3 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

A very warm welcome to everybody from my side. Before we get into our presentation today, I would like to give some initial statements. First of all, we announced on the 26th of September that Jasper has stepped down as CFO of Redcar, but will remain with the company until the end of the year for a smooth transition. As part of this smooth transition, Jasper and myself will today make this on-earning call like we did also in the past. Yeah. Secondly, we also announced on the 26th of September that we will present a successor rather soon. This statement still holds true. Please be aware that due to strict market regulations, we cannot give any additional information on this topic today. And number three, as you have seen the development of our share price this year, as you can imagine, we are not satisfied with this at all. and we take it very serious. To us, it is an incentive to continue to deliver on our strategy and execution and to deliver results. We want to use this earning call also to bring three key messages across. First of all, we are scaling RX across the entire P&L from top line to full results. Secondly, we are strengthening our already positive operating cash flow and are fully funded to execute on our strategy. And number three, our Capital Light business model is set up to scale and generate cash. Having said this, let's have a look into the agenda of today. First of all, we would like to talk about financial performance, then an update on RX Germany, and then number three, outlook and guidance 2025. We start with the financial performance Let's look into the nine-month financial highlights. Our group sales are up 27% year-over-year. It's a continued strong growth. It's fully organic, and it happens both in non-RX and in DRX business areas. Our non-R...